BENEDETTI, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 6.730
EU - Europa 3.842
AS - Asia 1.497
SA - Sud America 193
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 12.392
Nazione #
US - Stati Uniti d'America 6.685
UA - Ucraina 782
SE - Svezia 507
IT - Italia 482
RU - Federazione Russa 448
SG - Singapore 447
IE - Irlanda 440
DE - Germania 380
CN - Cina 341
DK - Danimarca 281
TR - Turchia 260
HK - Hong Kong 250
BR - Brasile 180
FI - Finlandia 168
GB - Regno Unito 151
KR - Corea 151
FR - Francia 115
CI - Costa d'Avorio 59
MA - Marocco 49
CA - Canada 38
BE - Belgio 23
PL - Polonia 20
AT - Austria 15
IN - India 13
NL - Olanda 13
EU - Europa 7
RS - Serbia 7
JP - Giappone 5
MX - Messico 5
UZ - Uzbekistan 5
EC - Ecuador 4
EG - Egitto 4
IR - Iran 4
PK - Pakistan 4
CO - Colombia 3
RO - Romania 3
TW - Taiwan 3
AU - Australia 2
BD - Bangladesh 2
HN - Honduras 2
IQ - Iraq 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
TN - Tunisia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
EE - Estonia 1
GA - Gabon 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
PE - Perù 1
PS - Palestinian Territory 1
UY - Uruguay 1
VN - Vietnam 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 12.392
Città #
Chandler 918
Jacksonville 807
Fairfield 575
Dublin 439
Boardman 436
Ashburn 377
Wilmington 290
Des Moines 288
Woodbridge 268
Hong Kong 250
Houston 232
New York 224
Singapore 217
Cambridge 188
Centro 182
Seattle 178
Lawrence 174
Princeton 174
San Mateo 166
Ann Arbor 165
Moscow 93
San Diego 75
The Dalles 74
Abidjan 59
Beijing 56
Turin 45
London 40
Los Angeles 36
Guangzhou 35
Washington 30
Wuhan 28
Ottawa 27
Brussels 23
Shanghai 22
Ancona 21
São Paulo 19
Marche 18
Helsinki 17
Redmond 16
Norwalk 15
Dallas 14
Wuxi 14
Kilburn 13
Kraków 13
Milan 13
Nuremberg 12
Torre Annunziata 12
Jiaxing 11
Pune 11
Izmir 9
Civitanova Marche 8
Rio de Janeiro 8
Santa Clara 8
Belgrade 7
Chiswick 7
Chicago 6
Falls Church 6
Munich 6
Senigallia 6
Vienna 6
Belo Horizonte 5
Brooklyn 5
Falkenstein 5
Fayetteville 5
Perugia 5
Sorocaba 5
Stockholm 5
Tashkent 5
Toronto 5
Turku 5
Warsaw 5
Acton 4
Aversa 4
Brasília 4
Curitiba 4
Jesi 4
Lunano 4
Mexico City 4
Montreal 4
New Bedfont 4
Porto 4
Porto Recanati 4
Redwood City 4
Shaoxing 4
Shenzhen 4
Bari 3
Betim 3
Buffalo 3
Cariacica 3
Council Bluffs 3
Falerone 3
Frankfurt am Main 3
Hangzhou 3
Hounslow 3
Jaboticabal 3
Nanjing 3
Naples 3
Palermo 3
Petrolina 3
Pouso Alegre 3
Totale 7.643
Nome #
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 132
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 124
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 115
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 113
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 109
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 108
Descriptive epidemiology of cholangiocarcinoma in Italy. 107
Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals 106
Hepatitis E in a region of Italy: An emerging autochthonous infection? 106
Ethyl caffeate from Verdicchio wine: chromatographic purification and in vivo evaluation of its antifibrotic activity. 105
Ethyl caffeoate: Liquid chromatography–tandem mass spectrometric analysis in Verdicchio wine and effects on hepatic stellate cells and intracellular peroxidation 104
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 104
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 102
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 101
Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. 99
Clinical implications of novel aspects of biliary pathophysiology. 99
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 98
Plasma membrane order parameter in periportal and perivenular hepatocytes isolated from ethanol-treated rats. 98
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 96
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 95
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 95
Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy 95
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 94
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 93
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 93
Primary biliary cirrhosis: modalities of injury and death in biliary epithelium. 92
Leptin enhances cholangiocarcinoma cell growth. 92
Aging and the Biological Response to Liver Injury 92
Biologic Drugs in Crohn's Disease and Ulcerative Colitis: Safety Profile 91
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 90
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 89
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 89
The Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells. 88
Glucagon-like peptide-1receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced bya high-fat diet in nonalcoholic steatohepatitis 88
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 88
Transforming growth factor beta 1 increases the number of apoptotic bodies and decreases intracellular pH in isolated periportal and perivenular rat hepatocytes. 86
Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. 86
Fibrogenic effect of oxidative stress on rat hepatic stellate cells. 86
Postoperative recurrence of crohn’s disease: Pathophysiology, diagnosis and treatment 86
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 85
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 85
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 84
Current targets for Primary Sclerosing cholangitis 84
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 84
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 84
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 83
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 83
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 83
Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. 82
Age and sex related changes of plasma membrane fluidity in isolated rat hepatocytes 82
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 82
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. 80
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 79
Observer agreement in endoscopic assessment of ulcerative colitis. 79
Evidence that plasma membrane fluidity of isolated hepatocytes is modified by exposure to microtubule-depolymerizing drugs 79
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 79
Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. 78
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 78
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 78
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 77
Oxidative damage and celiac disease: role of the enzyme paraoxonase associated with high-density lipoprotein (HDL) 77
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 76
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct ligated rats 76
Vitamin E in chronic liver diseases and liver fibrosis. 76
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 75
CAMP STIMULATES THE SECRETORY AND PROLIFERATIVE CAPACITY OF THE RAT BILIARY EPITHELIUM THROUGH CHANGES IN THE PKA/SRC/MEK/ERK1/2 PATHWAY 75
Regulation of intracellular pH in isolated periportal and perivenular rat hepatocytes. 75
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 75
Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. 75
Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. 74
[Cholestasis. Recent diagnostic and therapeutic acquisitions]. 74
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 74
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency 74
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 74
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 73
The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. 73
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 73
Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver 72
Mycosis Fungoides-like Eruption and Infliximab 72
Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study. 72
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 71
Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells. 71
Morphological features and modulation of the intrahepatic biliary epithelium. 70
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo. 70
Alpha-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca(2+)- and PKC-dependent stimulation of cAMP 69
A quantitative evaluation of apoptotic bodies in rat liver. 69
The significance of genetics for cholangiocarcinoma development 69
Endogenous opioid peptides and chronic liver disease: from bedside to bench. 68
Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt 68
Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells. 68
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 68
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 67
Subcellular changes and apoptosis induced by ethanol in rat liver. 67
Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liver. 67
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis 67
Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/Gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, Ca(2+)-, and protein kinase C alpha-dependent mechanisms. 67
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. 66
Effetti salutistici delle bevande alcoliche in rapporto al contenuto di sostanze antiossidanti naturali 66
Immunohistochemical identification of proliferating cells following dimethylnitrosamine-induced liver injury. 66
Ethyl caffeoate: in vivo evaluation of its antifibrotic activity 65
Totale 8.386
Categoria #
all - tutte 77.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020302 0 0 0 0 0 0 0 0 0 0 57 245
2020/20212.374 147 256 326 70 255 138 221 157 226 201 226 151
2021/20221.435 82 370 23 55 11 64 86 101 74 155 143 271
2022/20232.702 228 285 187 216 190 521 4 171 660 20 154 66
2023/20241.426 265 45 87 243 231 295 24 29 12 26 14 155
2024/20252.185 333 276 106 24 83 122 198 83 631 177 152 0
Totale 12.685